When to Avoid Durvalumab in Cancer Treatment
Durvalumab (Imfinzi) emerges as a promising immunotherapy option for challenging cancer cases like non-small cell lung cancer. With its targeted approach to immuno-oncology, understanding its benefits, contraindications, and potential side effects is crucial. Careful assessment of medical conditions and possible interactions ensures patients and healthcare providers make informed decisions for effective cancer management. Contraindications for […]
3 minute read